RSS

Dr Niklas Sandler

Dr Niklas Sandler, chief technology officer at Nanoform, explains why the use of nanonisation and artificial intelligence (AI) can help pharmaceutical manufacturers unlock added value for bioavailable nanoparticles. Read more

Opinion